MOH Stock Analysis
NYQ · Healthcare · Healthcare Plans
$190.86
-2.45 (-1.27%)
MOH Interactive Price Chart & Trading Signals
MOH Stock Snapshot — Valuation, Risk & Technical Signals
MOH Key Fundamentals, Analyst Targets & Company Profile
Key Financial Ratios
Marktkapitalisatie
$9.96B
P/E
1272.40
Forward P/E
19.59
PEG
0.89
P/B
2.38
EPS
$0.15
Dividendrendement
—
52W bereik
$121.06 – $244.89
Beta
0.76
Volume
0.7M
ROE
-0.2%
Winstmarge
-0.0%
Omzetgroei
-5.7%
Brutomarge
8.4%
EV/EBITDA
12.82
Analystendoel
$209.12
The trailing price-to-earnings ratio stands at 1272.4x. Forward P/E of 19.6x implies earnings expansion expected. Price-to-book is 2.38x. EV/EBITDA sits at 12.82x. Market capitalization is $9.96B. Revenue is contracting at -5.7% on a trailing basis. Earnings are compressing at -75.3%. Beta of 0.76 indicates defensive profile.
Analyst Consensus
Aanbeveling
Hold
Doel laag
$147.00
Doel gemiddeld
$209.12
Doel hoog
$266.00
Gebaseerd op 17 analisten
Over MOH
Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces in the United States. It operates through Medicaid, Medicare, Marketplace, and Other segments. The company was founded in 1980 and is headquartered in Long Beach, California.
MOH Deep Dive Analysis
Bottom Line
Verdict
OvervaluedBest for
General investorWatch out for
Premium valuation, Revenue contraction, Earnings declineNon-zero inputs
4/5Counts non-zero values for price, P/E, beta, macro risk, and revenue growth; zero may mean unavailable or be a genuine zero.
Molina Healthcare, Inc. (MOH) trades above our multi-model fair value estimate of $89.99 by approximately 52.8%. Trailing P/E: 1272.4x. Recent growth metrics show revenue growth of -5.7% and earnings growth of -75.3%. Risk profile: defensive beta of 0.76. Consensus: hold.
Valuation, Growth & Risk
Valuation
Overvalued
P/E 1272.4x
Price is above what fundamentals suggest.
Growth
Contracting
Rev -5.7%
Top-line revenue is shrinking.
Risk
Low
Beta 0.76
Movement is likely to track the broader market.
Valuation Snapshot
Molina Healthcare, Inc. (MOH) trades above our multi-model fair value estimate of $89.99 by approximately 52.8%. The trailing price-to-earnings ratio stands at 1272.4x. Forward P/E of 19.6x suggests earnings compression ahead. Price-to-sales is 0.2x. Price-to-book is 2.4x. EV/EBITDA sits at 12.8x. Market capitalization is $9.96B.
Why it matters: Paying a premium works only if the company keeps growing faster than expected.
Growth & Profitability
Revenue is contracting at -5.7% on a trailing basis. Earnings are compressing at -75.3%. Return on assets is 1.2%.
Why it matters: Falling revenue can signal losing market share or industry headwinds.
Risk Profile
Beta of 0.76 indicates defensive profile. Net debt position is $-4962000384.00.
Why it matters: Lower risk means steadier returns, but often with less upside in bull markets.
Analyst Context
Analyst consensus target of $209.12 implies 9.6% upside. Target range spans $147.00 to $266.00. 17 analysts cover the stock. Consensus recommendation: hold.
Why it matters: Analyst targets reflect what professionals expect over 12 months. A wide gap between price and target can mean the market disagrees with the consensus.
Data Methodology & Sources
Market Data (Facts)
- Price, volume, and market cap: Yahoo Finance (may be delayed)
- P/E, EPS, revenue, and debt: Yahoo Finance fundamentals
- Analyst estimates: Yahoo Finance (coverage and update times vary)
- Insider transactions: Yahoo Finance (reporting may be delayed)
QuantSoar Model (Derived)
- Fair value: available outputs from seven models; outliers are filtered using MAD (k=3.5), then combined with fixed model weights.
- Margin of Safety = (Fair Value − Displayed Price) / Displayed Price × 100
- Composite Score: 40% Value + 30% Momentum + 30% Risk
- Verdict Gauge: Base 50 + Valuation (up to ±25) + Whale sentiment (up to ±10) + Insider buying (+5) + Macro risk (up to ±10) + Technical signal (up to ±10). Analyst consensus is separate.
Model outputs are estimates based on available data and are not investment advice. Cross-check with primary sources before making investment decisions.
MOH Overvalued
Molina Healthcare, Inc. (MOH) trades above our multi-model fair value estimate of $89.99 by approximately 52.8%.
Frequently Asked Questions
ValuationIs MOH stock overvalued right now?
ValuationWhat is MOH fair value based on current fundamentals?
RiskHow risky is MOH compared with other stocks?
GrowthIs MOH still growing?
AnalystWhat do analysts think about MOH?
CatalystWhat could change the investment case for MOH?
Related Stocks
เกี่ยวกับผู้เขียน
Phasakorn Traklang (Peach) — ผู้ก่อตั้ง
ภาสกร ตรากลาง (พีช) เป็นผู้ก่อตั้ง QuantSoar และนักวิจัยการลงทุนเชิงปริมาณที่เชี่ยวชาญด้านการประเมินมูลค่าหุ้นหลายโมเดล การวิเคราะห์กระแสสถาบัน และการสร้างพอร์ตแบบเป็นระบบ เขาสร้างแพลตฟอร์มการเงินที่ขับเคลื่อนด้วยข้อมูลเพื่อให้บริการนักลงทุนรายย่อยทั่วโลก
เชื่อมต่อ LinkedInInvestment Disclaimer: Tax treatment can depend on tax residence, account type, and tax year. This information is general and is not personal tax or investment advice. SEC
Gegevens: Yahoo Finance / SEC EDGAR / Alpha Vantage / Finnhub